Max Borgström, Mats Fredrikson, Magnus Vrethem, Pierfrancesco Mirabelli, Hans Link, Yumin Huang-Link
{"title":"对 \"多发性硬化症 6.8 年升级治疗期间视网膜厚度和脑容量的变化 \"的勘误","authors":"Max Borgström, Mats Fredrikson, Magnus Vrethem, Pierfrancesco Mirabelli, Hans Link, Yumin Huang-Link","doi":"10.1155/2023/9764870","DOIUrl":null,"url":null,"abstract":"<p>In the article titled “Changes in Retinal Thickness and Brain Volume during 6.8-Year Escalating Therapy for Multiple Sclerosis” [<span>1</span>], incorrect versions of Figures 1(a) and 1(b) were published due to an error in the production process. Specifically, “baseline” and “high-efficacy DMT” on the <i>x</i>-axis are incorrectly labelled. In addition, the <i>x</i>-axis labels are displaced from the corresponding bar chart columns. The correct figures are shown below.</p>","PeriodicalId":6939,"journal":{"name":"Acta Neurologica Scandinavica","volume":"2023 1","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/9764870","citationCount":"0","resultStr":"{\"title\":\"Erratum to “Changes in Retinal Thickness and Brain Volume during 6.8-Year Escalating Therapy for Multiple Sclerosis”\",\"authors\":\"Max Borgström, Mats Fredrikson, Magnus Vrethem, Pierfrancesco Mirabelli, Hans Link, Yumin Huang-Link\",\"doi\":\"10.1155/2023/9764870\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In the article titled “Changes in Retinal Thickness and Brain Volume during 6.8-Year Escalating Therapy for Multiple Sclerosis” [<span>1</span>], incorrect versions of Figures 1(a) and 1(b) were published due to an error in the production process. Specifically, “baseline” and “high-efficacy DMT” on the <i>x</i>-axis are incorrectly labelled. In addition, the <i>x</i>-axis labels are displaced from the corresponding bar chart columns. The correct figures are shown below.</p>\",\"PeriodicalId\":6939,\"journal\":{\"name\":\"Acta Neurologica Scandinavica\",\"volume\":\"2023 1\",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2023-10-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/9764870\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Neurologica Scandinavica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/2023/9764870\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neurologica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2023/9764870","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Erratum to “Changes in Retinal Thickness and Brain Volume during 6.8-Year Escalating Therapy for Multiple Sclerosis”
In the article titled “Changes in Retinal Thickness and Brain Volume during 6.8-Year Escalating Therapy for Multiple Sclerosis” [1], incorrect versions of Figures 1(a) and 1(b) were published due to an error in the production process. Specifically, “baseline” and “high-efficacy DMT” on the x-axis are incorrectly labelled. In addition, the x-axis labels are displaced from the corresponding bar chart columns. The correct figures are shown below.
期刊介绍：
Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience. The journal''s scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area. Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders. Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders. Priority will be given to review of topical subjects. Papers requiring rapid publication because of their significance and timeliness will be included as ''Clinical commentaries'' not exceeding two printed pages, as will ''Clinical commentaries'' of sufficient general interest. Debate within the speciality is encouraged in the form of ''Letters to the editor''. All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
